Related content

Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α

By        

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2167-2175

Spandidos Publications

Access to resources Recommend Favorite

Protein kinase C-α downregulates estrogen receptor-α by suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells

By                    

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1423-1428

Spandidos Publications

Access to resources Recommend Favorite

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

By Thrane Susan  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

By Ignatov Atanas  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 457-466

Springer Publishing Company

Access to resources Recommend Favorite

Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

By Søiland Håvard   Skaland Ivar   Varhaug Jan Erik   Kørner Hartwig   Janssen Emiel   Gudlaugsson Einar   Baak Jan   Søreide Jon Arne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 514-521

Informa Healthcare

Access to resources Recommend Favorite